Skip to main content

Table 2 univariate analysis for LC, FFHF and OS

From: Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease

  LC FFHF OS
  1-year rate p value 1-year rate p value 1-year rate p value
gender
male 88% 0.279 44% 0.679 83% 0.055
female 94% 41% 67%
age
≤ median (64 yrs) 92% 0.265 40% 0.687 77% 0.76
> median 90% 43% 75%
histology
HCC 92% 0.492 41% 0.895 68% 0.701
MD 89% 40% 84%
KPS
≤70 100% 0.425 42% 0.579 50% 0.028
> 70 90% 42% 79%
GTV
≤ median (14.6 ccm) 100% 0.535 46% 0.794 80% 0.416
> median 88% 44% 77%
BED
≤ 100 87% 0.651 38% 0.419 75% 0.806
>  100 94% 48% 77%
lesions
single 97% 0.011 49% 0.047 80% < 0.001
multiple 67% 19% 40%
  1. LC: Local control, FFHF: Freedom from hepatic failure, OS: Overall survival, yrs.: years, HCC: hepatocellular carcinoma, MD: metastastic disease, KPS: Karnofsky performance score, GTV: Gross tumor volume (measured per patient on free-breathing CT), ccm: cubic centimeters, BED: biological equivalent dose